New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
07:35 EDTNLNKNewLink Genetics price target raised to $35 from $23 at Canaccord
Canaccord is more optimistic that the P3 IMPRESS trial of HyperAcute Pancreas in resected pancreatic cancer could meet its primary endpoint of an improvement in overall survival vs. placebo following a management meeting. Shares are Buy rated.
News For NLNK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 1, 2015
18:29 EDTNLNKEbola vaccine licensed to NewLink, Merck found safe, elicited antibody responses
Subscribe for More Information
March 30, 2015
12:43 EDTNLNKNewLink Genetics April volatility elevated
Subscribe for More Information
March 27, 2015
13:22 EDTNLNKNewLink Genetics April volatility elevated
NewLink Genetics April call option implied volatility is at 156, May is at 138, July is at 106; compared to its 15-week average of 113 according to Track Data, suggesting large near term price movement.
March 23, 2015
14:16 EDTNLNKNewLink Genetics April volatility elevated at 157
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use